您的位置: 首页 > 农业专利 > 详情页

CONJUGUÉS ANTICORPS-MÉDICAMENT
专利权人:
Daiichi Sankyo Company; Limited
发明人:
申请号:
EP19206764.3
公开号:
EP3632471A1
申请日:
2013.10.10
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
As an antitumor drug which is excellent in terms of antitumor effect and safety, there is provided an antibody-drug conjugate in which an antitumor compound represented by the following formula is conjugated to an anti-B7-H3 antibody via a linker having a structure represented by the following formula: -L1-L2-LP-NH-(CH2)n1-La-Lb-Lc- wherein the antibody is connected to the terminal of L1, and the antitumor compound is connected to the terminal of Lc with the nitrogen atom of the amino group at position 1 as a connecting position.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充